Stock ATNM ACTINIUM PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Actinium Pharmaceuticals, Inc.

Equities

ATNM

US00507W2061

Real-time Estimate Cboe BZX
Other stock markets
 09:31:28 2024-04-29 am EDT 		5-day change 1st Jan Change
6.87 USD 0.00% Intraday chart for Actinium Pharmaceuticals, Inc. +0.29% +35.24%
Apr. 26 Actinium Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Apr. 18 Actinium Pharmaceuticals, Inc. Highlights Ability of Iomab-B to Overcome High-Risk TP53 Mutation Resulting in Significant Improvement in Overall Survival in Patients with Active Relapsed Refractory AML at the European Bone Marrow Transplant Annual Meeting CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
ACTINIUM PHARMACEUTICALS, INC. Stock Actinium Pharmaceuticals, Inc.
 205M -
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
 103B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
 95.28B
ARGENX SE Stock argenx SE
 22.15B -
BIONTECH SE Stock BioNTech SE
 21.02B -
GENMAB A/S Stock Genmab A/S
 18.15B
  1. Stock Market
  2. Equities
  3. ATNM Stock
  4. Charts Actinium Pharmaceuticals, Inc.
  5. Sector Chart